학술논문
Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (p Is) with metastatic breast cancer (MBC) t ea led in first line with paclitaxel (P) and BEV-A Gineco study.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755